Skip to content

Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation Ablation

Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation Ablation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01724437
Enrollment
102
Registered
2012-11-09
Start date
2009-11-30
Completion date
2012-11-30
Last updated
2022-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Ablation Strategies, Paroxysmal Atrial Fibrillation

Brief summary

to assess the near-term (12 months) efficacy of pulmonary vein isolation.

Detailed description

The aim of the study was to assess the near-term (12 months) efficacy of pulmonary vein isolation using a standard approach compared to application of an additional acute procedural endpoint of unexcitability along the ablation line.

Interventions

DEVICEcatheter based pulmonary vein isolation

catheter based ablation using irrigated catheters and radiofrequency energy as in clinical practice

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Open Label

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* written informed consent * age \> 18 years * paroxysmal atrial fibrillation

Exclusion criteria

* structural heart disease * intracardiac thrombus * reversible causes of atrial fibrillation * inability to take warfarin

Design outcomes

Primary

MeasureTime frameDescription
time to AF and AT recurrence12 monthsrecurrence of AF as assessed by 3 day holter monitoring, assessment of AT recurrence using 3 day holter monitoring

Secondary

MeasureTime frameDescription
procedure durationcompleted (15 months)time needed to complete the procedure
procedure safetyup to three days after the procedurecomplication such as groin hematoma, stroke and pericardial bleed prolonging the hospital stay will be assessed

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026